Publication
eDiscovery Around the Globe - 2015 in review
A cohesive collection of articles from around the world addressing evolving and trending aspects of discovery.
Global | Publication | March 3, 2016
Welcome to Norton Rose Fulbright’s Global e-Discovery 2015 “Year In Review” white paper.
As a global firm, representing clients in disputes across the world, we recognize that it’s important that all of our litigators understand how discovery impacts our clients’ cases both at home and abroad so our objective with this white paper series is to keep your organization abreast of the latest developments and trends in the fascinating world of e-Discovery.
The articles in this collection address two different aspects of discovery that we covered in 2015: Technology Assisted Review (“TAR”) and Forensics. We are also including a bonus article on the amendments to the Federal Rules of Civil Procedure that went into place on December 1, 2015 in the United States.
- The first article addresses Technology Assisted Review ("TAR") and how it is being used, adopted and approved around the world.
- The second article details forensics and its place in civil discovery around the world.
- The third article summarizes the discovery amendments to the Federal Rules of Civil Procedure and how they will affect your organization.
Recent publications
Publication
The GCR Guide to Life Sciences – Product denigration
Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .